Search research articles
Contact Us
Filters
Showing results (131-140 of 245) with videos related to
Page
of 25
Sort By:
Psychopharmacology
|
January 1, 1985
Tyramine pressor sensitivity changes during deprenyl treatment
T Sunderland, E A Mueller, R M Cohen, et al.
Biological Psychiatry
|
June 1, 1984
High dose naloxone in depression
M R Cohen, R M Cohen, D Pickar, et al.
The American Journal of Psychiatry
|
November 1, 1992
Regional cerebral glucose metabolism in bulimia nervosa
P J Andreason, M Altemus, A J Zametkin, et al.
Psychiatry Research
|
November 25, 2000
6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography
A M Elkashef, D Doudet, T Bryant, et al.
Psychopharmacology Bulletin
|
January 1, 1994
Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD). Preliminary findings
M Ernst, A J Zametkin, J A Matochik, et al.
Lancet (London, England)
|
November 14, 1981
Behavioural effects after high dose naloxone administration to normal volunteers
M R Cohen, R M Cohen, D Pickar, et al.
Archives of General Psychiatry
|
May 1, 1987
Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study
T Sunderland, P N Tariot, R M Cohen, et al.
Psychopharmacology Bulletin
|
January 1, 1985
Cognitive and behavioral sensitivity to scopolamine in Alzheimer patients and controls
T Sunderland, P N Tariot, E A Mueller, et al.
Psychopharmacology Bulletin
|
January 1, 1996
Selegiline in adults with attention deficit hyperactivity disorder: clinical efficacy and safety
M Ernst, L L Liebenauer, P H Jons, et al.
European Journal of Pharmacology
|
May 7, 1982
Cardiovascular changes in response to selective monoamine oxidase inhibition in the rat
R M Cohen, I C Campbell, I Yamaguchi, et al.
Page
of 25
Search research articles
Search
Showing results (131-140 of 245) with videos related to
Sort By:
Page
of 25
Psychopharmacology
|
January 1, 1985
Tyramine pressor sensitivity changes during deprenyl treatment
T Sunderland, E A Mueller, R M Cohen, et al.
Biological Psychiatry
|
June 1, 1984
High dose naloxone in depression
M R Cohen, R M Cohen, D Pickar, et al.
The American Journal of Psychiatry
|
November 1, 1992
Regional cerebral glucose metabolism in bulimia nervosa
P J Andreason, M Altemus, A J Zametkin, et al.
Psychiatry Research
|
November 25, 2000
6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography
A M Elkashef, D Doudet, T Bryant, et al.
Psychopharmacology Bulletin
|
January 1, 1994
Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD). Preliminary findings
M Ernst, A J Zametkin, J A Matochik, et al.
Lancet (London, England)
|
November 14, 1981
Behavioural effects after high dose naloxone administration to normal volunteers
M R Cohen, R M Cohen, D Pickar, et al.
Archives of General Psychiatry
|
May 1, 1987
Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study
T Sunderland, P N Tariot, R M Cohen, et al.
Psychopharmacology Bulletin
|
January 1, 1985
Cognitive and behavioral sensitivity to scopolamine in Alzheimer patients and controls
T Sunderland, P N Tariot, E A Mueller, et al.
Psychopharmacology Bulletin
|
January 1, 1996
Selegiline in adults with attention deficit hyperactivity disorder: clinical efficacy and safety
M Ernst, L L Liebenauer, P H Jons, et al.
European Journal of Pharmacology
|
May 7, 1982
Cardiovascular changes in response to selective monoamine oxidase inhibition in the rat
R M Cohen, I C Campbell, I Yamaguchi, et al.
Page
of 25